Merck & Co., Inc.
MRK · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $64,168,000 | $60,115,000 | $59,283,000 | $48,704,000 |
| % Growth | 6.7% | 1.4% | 21.7% | – |
| Cost of Goods Sold | $15,193,000 | $16,126,000 | $17,411,000 | $13,626,000 |
| Gross Profit | $48,975,000 | $43,989,000 | $41,872,000 | $35,078,000 |
| % Margin | 76.3% | 73.2% | 70.6% | 72% |
| R&D Expenses | $17,938,000 | $30,531,000 | $13,548,000 | $12,245,000 |
| G&A Expenses | $7,700,000 | $7,584,000 | $7,469,000 | $7,403,000 |
| SG&A Expenses | $10,100,000 | $9,884,000 | $9,669,000 | $9,403,000 |
| Sales & Mktg Exp. | $2,400,000 | $2,300,000 | $2,200,000 | $2,000,000 |
| Other Operating Expenses | $716,000 | $620,000 | $373,000 | $231,000 |
| Operating Expenses | $28,754,000 | $41,035,000 | $23,590,000 | $21,879,000 |
| Operating Income | $20,221,000 | $2,954,000 | $18,282,000 | $13,199,000 |
| % Margin | 31.5% | 4.9% | 30.8% | 27.1% |
| Other Income/Exp. Net | -$285,000 | -$1,065,000 | -$1,838,000 | $680,000 |
| Pre-Tax Income | $19,936,000 | $1,889,000 | $16,444,000 | $13,879,000 |
| Tax Expense | $2,803,000 | $1,512,000 | $1,918,000 | $1,521,000 |
| Net Income | $17,117,000 | $365,000 | $14,519,000 | $13,049,000 |
| % Margin | 26.7% | 0.6% | 24.5% | 26.8% |
| EPS | 6.76 | 0.14 | 5.73 | 5.16 |
| % Growth | 4,728.6% | -97.6% | 11% | – |
| EPS Diluted | 6.74 | 0.14 | 5.71 | 5.14 |
| Weighted Avg Shares Out | 2,532,000 | 2,607,143 | 2,532,000 | 2,530,000 |
| Weighted Avg Shares Out Dil | 2,541,000 | 2,547,000 | 2,542,000 | 2,538,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $415,000 | $365,000 | $157,000 | $36,000 |
| Interest Expense | $1,271,000 | $1,146,000 | $962,000 | $806,000 |
| Depreciation & Amortization | $4,499,000 | $3,872,000 | $3,909,000 | $3,214,000 |
| EBITDA | $25,706,000 | $6,907,000 | $21,315,000 | $17,899,000 |
| % Margin | 40.1% | 11.5% | 36% | 36.8% |